Wordt geladen...
Design of the Redefining Therapy in Early COPD Study
Redefining Therapy in Early COPD (RETHINC) is a 12-week multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of indacaterol/glycopyrrolate 27.5/15.6 mcg inhaled twice daily in symptomatic current and former smokers with respiratory symptom...
Bewaard in:
| Gepubliceerd in: | Chronic Obstr Pulm Dis |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
COPD Foundation Inc
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7883914/ https://ncbi.nlm.nih.gov/pubmed/32989941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.7.4.2020.0157 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|